SHL at PDA Vegas 2012 - Inspiring Integration: Development, Capabilities, Final Assembly

TAOYUAN, Taiwan, Oct. 11, 2012 /PRNewswire/ -- With the biopharmaceutical industry's drug delivery landscape in recent years quickly evolving to adapt to the introduction of new biologics drugs, a range of devices such as pen and auto injectors have also been introduced to improve the administration, safety and accuracy of the drug for end-users. As biopharmaceutical companies and device manufacturers come together to work on innovating such solutions, it is becoming more apparent that for a project to succeed it is crucial to find a partner that can provide streamlined key services. To promote the importance of integrating such services in the area of Development, Capabilities and Final Assembly, SHL will be focusing on the theme of Inspiring Integration during its presence at the 2012 PDA (The Universe of Pre-filled Syringes & Injection Devices) in Las Vegas USA at the Red Rock Resort from October 15-16th.

(Photo: http://photos.prnewswire.com/prnh/20121011/HK91123 )

As the PDA's theme this year happens to be "Integrating the Unmet Market Needs: Bringing it All Together for Tomorrow's Success", SHL believes that the Inspiring Integration topic speaks also to the same needs but at a device development and manufacturing level. As biopharmaceutical companies have gained extensive device knowledge over the years, SHL hopes to now share with customers about the importance of working with a partner that can provide a range of key services and capabilities to streamline all stages and ultimately speed up time-to-market while ensuring quality and protecting IP.

Commenting on this year's attendance and theme, Marketing Director, Steven Kaufman says, "It is once again an honor for us to attend such a prestigious event. Over the years the PDA has attracted various industry experts to speak, attend and exhibit at this event, this allows device companies like ourselves to interact with key individuals to better understand the true needs of biopharmaceutical companies and learn what we can do to integrate a range of key expertise and services. Although we have many devices in our pipeline, this year we decided to focus on the importance of integrating design & development, in-house capabilities and final assembly and streamlining them for customers so we can maximize efficiency and quality. That said, we of course welcome customers to ask about our latest devices"

Visit us at BOOTH#103 to find out more about our Products, Services and Capabilities.

About SHL

SHL is the world's largest privately-owned designer, developer and manufacturer of advanced drug delivery devices. We have over 2,000 staff globally, with our primary design centers located in Sweden and the USA and manufacturing centers located in Asia. Final assembly, labeling and packaging services for drug delivery devices are also offered in SHL's newest facility in Florida.

SHL supplies auto injectors, pen injectors and inhaler systems to global pharmaceutical and biotech companies. Significant investment in R&D has enhanced our broad pipeline of "next generation" drug delivery systems. These innovative devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision and the ability to accommodate high viscosities.

Our organization consists of several distinct group companies:

SHL Medical designs, develops and manufactures advanced drug delivery devices for leading pharmaceutical and biotech companies

SHL Healthcare develops and manufactures equipment solutions for home, hospital and long term care use

SHL Technologies provides contract manufacturing and engineering services for the production of complex medtech and industrial products

SHL Pharma offers final assembly, labeling and packaging services of drug delivery devices to biopharmaceutical companies

For additional information visit www.shl-group.com or contact us at [email protected]

SHL Media Contact:
Steven R. Kaufman
Marketing Director
+886-3-2170303
[email protected]

SOURCE SHL Group